Abstract：Objective: To detect and analyze the specificity and sensitivity of serum immune cytokines in mycobacterium tuberculosis (TB) lung disease, and to evaluate its diagnostic value. Methods: A total of 139 patients with suspected pulmonary tuberculosis who were treated in Hebei Chest Hospital from Nov. 2020 to Oct. 2022 were retrospectively selected as the research subjects. According to the latest diagnostic criteria for tuberculosis implemented in 2018 (WS288-2017), 69 cases of confirmed tuberculosis were included in the tuberculosis group, and 70 cases of non-tuberculosis were included in the non-tuberculosis group. The serum levels of immune-related cytokines IL-6, IL-17, and IFN-α were detected by flow immunofluorescence assay, and the diagnostic efficacy of the three factors in tuberculosis was analyzed. Results: The levels of IL-6 and IL-17 in patients with tuberculosis were significantly higher than those in patients without tuberculosis (P<0.05). The concentration of IFN-α in the TB group was slightly higher than that in the non-TB group, There's no statistically significant difference (P>0.05). ROC curve analysis showed that the area under the curve (AUC) of IL-6, IL-17, and IFN-α detection was 0.658, 0.734and 0.571, respectively (P < 0.001). Conclusion: The detection of IL-6 and IL-17 has certain clinical value in the auxiliary diagnosis of tuberculosis.
刘战地, 孙明玥, 田二朋, 马伟立, 邸红芹. IFN-α IL-6和IL-17检测对结核病辅助诊断价值[J]. 河北医学, 2024, 30(6): 942-945.
LIU Zhandi, SUN Mingyue, TIAN Erpeng, et al. Evaluation of the Auxiliary Diagnostic Value of IFN-α IL-6 and IL-17 for Tuberculosis. HeBei Med, 2024, 30(6): 942-945.
[1] Zhou G, Luo Q, Luo S, et al. Interferon-γ release assays or tuberculin skin test for detection and management of latent tuberculosis infection: a systematic review and meta-analysis[J].Lancet Infect Dis,2020,20 (12):1457-1469. [2] Zellweger JP, Sotgiu G, Corradi M, et al. The diagnosis of latent tuberculosis infection (LTBI): currently available tests, future developments, and perspectives to eliminate tuberculosis (TB)[J]. Med Lav,2020,111(3):170-183. [3] Nogueira M, Warren RB, Torres T. Risk of tuberculosis reactivation with interleukin (IL)-17 and IL-23 inhibitors in psoriasis-time for a paradigm change[J].Eur Acad Dermatol Venereol,2021,35(4):824-834. [4] Simmons J D,Stein C M,Seshadri C,et al. Immunological mechanisms of human resistance to persistent mycobacterium tuberculosis infection[J]. Nat Rev Immunol,2018,18(9):575-589. [5] Liu C H,Liu H,Ge B. Innate immunity in tuberculosis:host defense vs pathogen evasion[J]. Cellular & Molecular Immunology,2017,14(12):963-975. [6] Guzman-Beltran S, Carreto-Binaghi L E, Carranza C,et al.Oxidative stress and inflammatory mediators in exhaled breath condensate of patients with pulmonary tuberculosis. a pilot study with a biomarker perspective[J]. Antioxidants,2021(10):1572. [7] Alvi SM, Ramraje NN, Patil VW, et al. Study of IL-6 and vitamin D3 in patients of pulmonary tuberculosis[J]. Indian Tuberc,2019,66 (3):337-345. [8] Joshi L, Ponnana M, Sivangala R, et al.Evaluation of TNF-α, IL-10 and IL-6 cytokine productionand their correlation with genotype variants amongst tuberculosis patients and their household contacts[J]. PLoS One,2015(10):137727. [9] Singh P P. Interleukin-6: a potential biomarker of the success of tuberculosis treatment[J]. Int Infect Dis,2016(45), 413. [10] Harrington LE, Hatton RD, Mangan PR, et al. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages[J]. Nat Immunol, 2005,6(11):1123-1132. [11] Yasuda K, Takeuchi Y, Hirota K. The pathogenicity of Th17 cells in autoimmune diseases[J]. Semin Immunopathol,2019,41(3):283-297. [12] Nogueira M, Warren RB, Torres T. Risk of tuberculosis reactivation with interleukin (IL)-17 and IL-23 inhibitors in psoriasis - time for a paradigm change[J].Eur Acad Dermatol Venereol,2021,35(4):824-834. [13] Torrado E, Cooper AM. IL-17 and Th17 cells in tuberculosis[J]. Cytokine Growth Factor Rev,2010,21(6):455-462. [14] 兰亚如,孙鹏,段相国,等.干扰素α对小鼠Tfh细胞分化的调控作用[J].动物医学进展,2020,41(02):18-22. [15] 陆霓虹,李杰.结核分枝杆菌致肺损伤的研究进展[J].中国医药科学,2022,12(16):33-36.
2024, Vol. 30 
冀公网安备13080202000677号